Drug company UCB's acquisition facility via BNP Paribas and Fortis Bank will be launched next week.
The loan will back its Eu4.4bn takeover of German rival Schwarz Pharma. The deal will be fully underwritten by the two bookrunners.UCB's cash and share offer amounts to Eu50 in cash per Schwarz ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com